Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Corine E. Delsing"'
Autor:
Stephan P. Keijmel, Elmer Krijger, Corine E. Delsing, Tom Sprong, Marrigje H. Nabuurs-Franssen, Chantal P. Bleeker-Rovers
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 8, Pp 1348-1356 (2015)
Differentiating acute Q fever from infections caused by other pathogens is essential. We conducted a retrospective case–control study to evaluate differences in clinical signs, symptoms, and outcomes for 82 patients with acute Q fever and 52 contro
Externí odkaz:
https://doaj.org/article/392b3235643f4e598a592f8b5a3dd9d9
Autor:
Linda M. Kampschreur, Marjolijn C.A. Wegdam-Blans, Peter C. Wever, Nicole H.M. Renders, Corine E. Delsing, Tom Sprong, Marjo E.E. van Kasteren, Henk Bijlmer, Daan Notermans, Jan Jelrik Oosterheert, Frans S. Stals, Marrigje H. Nabuurs-Franssen, Chantal P. Bleeker-Rovers
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 7, Pp 1183-1188 (2015)
Chronic Q fever, caused by Coxiella burnetii, has high mortality and morbidity rates if left untreated. Controversy about the diagnosis of this complex disease has emerged recently. We applied the guideline from the Dutch Q Fever Consensus Group and
Externí odkaz:
https://doaj.org/article/71f6abf9b05d46f38efb1ded89e60439
Autor:
Kathryn S Hensley, Marlou J Jongkees, Daryl Geers, Corine H GeurtsvanKessel, Yvonne M Mueller, Virgil A S H Dalm, Grigorios Papageorgiou, Hanka Steggink, Alicja Gorska, Susanne Bogers, Jan G den Hollander, Wouter F W Bierman, Luc B S Gelinck, Emile F Schippers, Heidi S M Ammerlaan, Marc van der Valk, Marit G A van Vonderen, Corine E Delsing, Elisabeth H Gisolf, Anke H W Bruns, Fanny N Lauw, Marvin A H Berrevoets, Kim C E Sigaloff, Robert Soetekouw, Judith Branger, Quirijn de Mast, Adriana J J Lammers, Selwyn H Lowe, Rory D de Vries, Peter D Katsikis, Bart J A Rijnders, Kees Brinkman, Anna H E Roukens, Casper Rokx
Publikováno v:
PLoS Medicine, Vol 19, Iss 10, p e1003979 (2022)
BackgroundVaccines can be less immunogenic in people living with HIV (PLWH), but for SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the vaccines currently approved in the Netherlands, the immunogenicity and reac
Externí odkaz:
https://doaj.org/article/9ad594b98b274203b73f9a4dbe6a6859
Autor:
Marlou J Jongkees, Daryl Geers, Kathryn S Hensley, Wesley Huisman, Corine H GeurtsvanKessel, Susanne Bogers, Lennert Gommers, Grigorios Papageorgiou, Simon P Jochems, Jan G den Hollander, Emile F Schippers, Heidi S M Ammerlaan, Wouter F W Bierman, Marc van der Valk, Marvin A H Berrevoets, Robert Soetekouw, Nienke Langebeek, Anke H W Bruns, Eliane M S Leyten, Kim C E Sigaloff, Marit G A van Vonderen, Corine E Delsing, Judith Branger, Peter D Katsikis, Yvonne M Mueller, Rory D de Vries, Bart J A Rijnders, Kees Brinkman, Casper Rokx, Anna H E Roukens
Publikováno v:
The Journal of Infectious Diseases, 227(5), 651-662. OXFORD UNIV PRESS INC
The Journal of Infectious Diseases, 227(5), 651-662. Oxford University Press
Jongkees, M J, Geers, D, Hensley, K S, Huisman, W, GeurtsvanKessel, C H, Bogers, S, Gommers, L, Papageorgiou, G, Jochems, S P, den Hollander, J G, Schippers, E F, Ammerlaan, H S M, Bierman, W F W, van der Valk, M, Berrevoets, M A H, Soetekouw, R, Langebeek, N, Bruns, A H W, Leyten, E M S, Sigaloff, K C E, van Vonderen, M G A, Delsing, C E, Branger, J, Katsikis, P D, Mueller, Y M, de Vries, R D, Rijnders, B J A, Brinkman, K, Rokx, C & Roukens, A H E 2023, ' Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination ', The Journal of infectious diseases, vol. 227, no. 5, pp. 651-662 . https://doi.org/10.1093/infdis/jiac451
The Journal of infectious diseases, 227(5), 651-662. Oxford University Press
The Journal of Infectious Diseases, 227(5), 651-662. Oxford University Press
Jongkees, M J, Geers, D, Hensley, K S, Huisman, W, GeurtsvanKessel, C H, Bogers, S, Gommers, L, Papageorgiou, G, Jochems, S P, den Hollander, J G, Schippers, E F, Ammerlaan, H S M, Bierman, W F W, van der Valk, M, Berrevoets, M A H, Soetekouw, R, Langebeek, N, Bruns, A H W, Leyten, E M S, Sigaloff, K C E, van Vonderen, M G A, Delsing, C E, Branger, J, Katsikis, P D, Mueller, Y M, de Vries, R D, Rijnders, B J A, Brinkman, K, Rokx, C & Roukens, A H E 2023, ' Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination ', The Journal of infectious diseases, vol. 227, no. 5, pp. 651-662 . https://doi.org/10.1093/infdis/jiac451
The Journal of infectious diseases, 227(5), 651-662. Oxford University Press
BackgroundThe COVIH study is a prospective coronavirus disease 2019 (COVID-19) vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels after primary vaccination. We evaluated whether an additional vaccination boost
Autor:
Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, Wesley Huisman, Corine H. GeurtsvanKessel, Susanne Bogers, Lennert Gommers, Grigorios Papageorgiou, Simon P. Jochems, Jan G. den Hollander, Emile F. Schippers, Heidi S.M. Ammerlaan, Wouter F.W. Bierman, Marc van der Valk, Marvin A.H. Berrevoets, Robert Soetekouw, Nienke Langebeek, Anke H.W. Bruns, Eliane M.S. Leyten, Kim C.E. Sigaloff, Marit G.A. van Vonderen, Corine E. Delsing, Judith Branger, Peter D. Katsikis, Yvonne M. Mueller, Rory D. de Vries, Bart J.A. Rijnders, Kees Brinkman, Casper Rokx, Anna H.E. Roukens
BackgroundThe COVIH study is a prospective SARS-CoV-2 vaccination study in people living with HIV (PLWH). Of the 1154 PLWH enrolled, 14% showed a reduced or absent antibody response after a primary vaccination regimen. As the response to an additiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed0a35fc8ac7a63de3461098077be0cf
https://doi.org/10.1101/2022.08.10.22278577
https://doi.org/10.1101/2022.08.10.22278577
Autor:
Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, Corine H. GeurtsvanKessel, Yvonne M. Mueller, Virgil A. S. H. Dalm, Grigorios Papageorgiou, Hanka Steggink, Alicja Gorska, Susanne Bogers, Jan G. den Hollander, Wouter F. W. Bierman, Luc B. S. Gelinck, Emile F. Schippers, Heidi S. M. Ammerlaan, Marc van der Valk, Marit G. A. van Vonderen, Corine E. Delsing, Elisabeth H. Gisolf, Anke H. W. Bruns, Fanny N. Lauw, Marvin A. H. Berrevoets, Kim C. E. Sigaloff, Robert Soetekouw, Judith Branger, Quirijn de Mast, Adriana J. J. Lammers, Selwyn H. Lowe, Rory D. de Vries, Peter D. Katsikis, Bart J. A. Rijnders, Kees Brinkman, Anna H. E. Roukens, Casper Rokx
Publikováno v:
PLOS Medicine. 20:e1004159
Autor:
Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, Corine H. GeurtsvanKessel, Yvonne M. Mueller, Virgil A.S.H. Dalm, Grigorios Papageorgiou, Hanka Steggink, Alicja Gorska, Susanne Bogers, Jan G. den Hollander, Wouter F.W. Bierman, Luc B.S. Gelinck, Emile F. Schippers, Heidi S.M. Ammerlaan, Marc van der Valk, Marit G.A. van Vonderen, Corine E. Delsing, Elisabeth H. Gisolf, Anke H.W. Bruns, Fanny N. Lauw, Marvin A.H. Berrevoets, Kim C.E. Sigaloff, Robert Soetekouw, Judith Branger, Quirijn de Mast, Adriana J.J. Lammers, Selwyn H. Lowe, Rory D. de Vries, Peter D. Katsikis, Bart J.A. Rijnders, Kees Brinkman, Anna H.E. Roukens, Casper Rokx
BackgroundVaccines can be less immunogenic in people living with HIV (PLWH), but for SARS-CoV-2 vaccinations this is unknown.Methods and FindingsA prospective cohort study to examine the immunogenicity of BNT162b2, mRNA-1273, ChAdOx1-S and Ad26.COV2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7528a462db3586b8c9c52ddd2c7ee031
https://doi.org/10.1101/2022.03.31.22273221
https://doi.org/10.1101/2022.03.31.22273221
Autor:
Mark A. A. Claassen, Bart J. A. Rijnders, Stephanie Popping, Corine E Delsing, D. W. M. Verhagen, Anton S M Dofferhoff, Charles A. Boucher, Dirk Posthouwer, Marjo E. E. van Kasteren, Wouter F W Bierman, Arne van Eeden, Joop E. Arends, David A. M. C. van de Vijver, Robert Soetekouw, Paul H. P. Groeneveld, Edgar J G Peters, Kamilla D. Lettinga, Sebastiaan J. Hullegie, Eliane M. S. Leyten, Guido E.L. van den Berk, F. N. Lauw, Anne Boerekamps, Frank P. Kroon
Publikováno v:
Boerekamps, A, van den Berk, G E, Lauw, F N, Leyten, E M, van Kasteren, M E, van Eeden, A, Posthouwer, D, Claassen, M A, Dofferhoff, A S, Verhagen, D W M, Bierman, W F, Lettinga, K D, Kroon, F P, Delsing, C E, Groeneveld, P H, Soetekouw, R, Peters, E J, Hullegie, S J, Popping, S, van de Vijver, D A M C, Boucher, C A, Arends, J E & Rijnders, B J 2018, ' Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy ', Clinical Infectious Diseases, vol. 66, no. 9, pp. 1360-1365 . https://doi.org/10.1093/cid/cix1007, https://doi.org/10.1093/cid/cix1007
Clinical Infectious Diseases, 66(9), 1360-1365
Clinical Infectious Diseases, 66(9), 1360-1365. Oxford University Press
Clinical Infectious Diseases, 66, 1360-1365
Clinical Infectious Diseases, 66, 9, pp. 1360-1365
Clinical Infectious Diseases, 66(9), 1360-1365
Clinical Infectious Diseases, 66(9), 1360-1365. Oxford University Press
Clinical Infectious Diseases, 66, 1360-1365
Clinical Infectious Diseases, 66, 9, pp. 1360-1365
Background. Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections in 95% of infected patients. Modeling studies predict that universal HCV treatment will lead to a decrease in the incidence of new infections but real-life data are l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b294746e56b813219ab13936a335d4a1
https://research.vumc.nl/en/publications/15cccc8b-4443-422a-841b-61ca5f1ba21e
https://research.vumc.nl/en/publications/15cccc8b-4443-422a-841b-61ca5f1ba21e
Autor:
Corine E Delsing, Chantal P. Bleeker-Rovers, Stephan P. Keijmel, Marrigje H. Nabuurs-Franssen, Tom Sprong, Elmer Krijger
Publikováno v:
Emerging Infectious Diseases, 21, 8, pp. 1348-56
Emerging Infectious Diseases, 21, 1348-56
Emerging Infectious Diseases
Emerging Infectious Diseases, 21, 1348-56
Emerging Infectious Diseases
Distinguishing acute Q fever from respiratory infections, fever, or hepatitis requires serologic testing or PCR.
Differentiating acute Q fever from infections caused by other pathogens is essential. We conducted a retrospective case–control st
Differentiating acute Q fever from infections caused by other pathogens is essential. We conducted a retrospective case–control st
Autor:
Monique Leclercq, Jos W. M. van der Meer, L. M. Kampschreur, Corine E Delsing, Tom Sprong, Hans Knoop, Michel van den Berg, Rogier Donders, Stephan P. Keijmel, Gijs Bleijenberg, Marrigje H. Nabuurs-Franssen, Chantal P. Bleeker-Rovers
Publikováno v:
Clinical Infectious Diseases, 64, 998-1005
Clinical infectious diseases, 64(8), 998-1005. Oxford University Press
Clinical Infectious Diseases, 64, 8, pp. 998-1005
Clinical infectious diseases, 64(8), 998-1005. Oxford University Press
Clinical Infectious Diseases, 64, 8, pp. 998-1005
Contains fulltext : 174731.pdf (Publisher’s version ) (Closed access) Background.: Approximately 20% of patients with acute Q fever will develop chronic fatigue, referred to as Q fever fatigue syndrome (QFS). The objective of this randomized contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddad0312317f4abd02096a8188305145
https://doi.org/10.1093/cid/cix013
https://doi.org/10.1093/cid/cix013